Weight-based administration of dalteparin in obese patients. Am J Health Syst Pharm. 2003;60(7):683-687. 106. Beyer-Westendorf J, Fo rster K, Pannach S, et al. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry. Blood. 2014;124(6):955-962. 107. Beynon C, Sakowitz OW, Sto rzinger D, et al. Intracranial haemorrhage in patients treated with direct oral anticoagulants. Thromb Res. 2015;136(3): 560-565. 108. Eerenberg ES, Middeldorp S, Levi M, Lensing AW, Bu ller HR. Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists. J Thromb Haemost. 2015;13(9):1590-1596. 109. Kumar R, Smith RE, Henry BL. A review of and recommendations for the management of patients with life-threatening dabigatran-associated hemorrhage: a single-center university hospital experience. J Intensive Care Med. 2015;30(8):462-472. 110. Pahs L, Beavers C, Schuler P. The real-world treatment of hemorrhages associated with dabigatran and rivaroxaban: a multicenter evaluation. Crit Pathw Cardiol. 2015;14(2):53-61. 111. Piccini JP, Garg J, Patel MR, et al; ROCKET AF Investigators. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. Eur Heart J. 2014;35(28):1873-1880. 112. Purrucker JC, Haas K, Rizos T, et al. Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants. JAMA Neurol. 2016;73(2):169-177. 113. Senger S, Keiner D, Hendrix P, Oertel J. New target-specific oral anticoagulants and intracranial bleeding: management and outcome in a single-center case series. World Neurosurg. 2016;88:132-139. 114. Granger CB, Lopes RD, Hanna M, et al. Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial [published correction appears in Am Heart J. 2015;169(4): 594]. Am Heart J. 2015;169(1):25-30. 115. Mahaffey KW, Hellkamp AS, Patel MR, et al. 